X. Ji, Li Huang, Zhipeng Du, Weijie Li, Fushun Yang
{"title":"Progress of cystic fibrosis","authors":"X. Ji, Li Huang, Zhipeng Du, Weijie Li, Fushun Yang","doi":"10.3760/CMA.J.ISSN.1673-436X.2020.03.015","DOIUrl":null,"url":null,"abstract":"Cystic fibrosis (CF) is an autosomal recessive hereditary disease with a low incidence in Asia.There are no epidemiological statistics on the incidence of CF in China.CF can lead to dysfunction in multi-system of the whole body.As a safe, fast and easy method, gene detection is becoming more and more important in CF diagnosis.However, the gene mutation spectrum of Chinese population has not yet been proposed.Multidisciplinary combination therapy and gene therapy are the new directions of CF study.At present, there are no guidelines and disease management suitable for the Chinese population.This article reviews the current situation, pathogenesis, clinical manifestations, gene diagnosis and treatment in China. \n \n \nKey words: \nCystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Sweat chloride test; Gene diagnosis","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"24 1","pages":"235-237"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Asthma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-436X.2020.03.015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Cystic fibrosis (CF) is an autosomal recessive hereditary disease with a low incidence in Asia.There are no epidemiological statistics on the incidence of CF in China.CF can lead to dysfunction in multi-system of the whole body.As a safe, fast and easy method, gene detection is becoming more and more important in CF diagnosis.However, the gene mutation spectrum of Chinese population has not yet been proposed.Multidisciplinary combination therapy and gene therapy are the new directions of CF study.At present, there are no guidelines and disease management suitable for the Chinese population.This article reviews the current situation, pathogenesis, clinical manifestations, gene diagnosis and treatment in China.
Key words:
Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Sweat chloride test; Gene diagnosis